This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Amy Jenkins
Program Manager at DARPA Biological Technologies Office


Dr. Amy Jenkins joined DARPA as a Program Manager in June 2019.  Her interests include the development of platforms for combatting infectious disease threats as well as novel manufacturing methods to enable rapid response. 

Prior to joining DARPA as a PM, Dr. Jenkins was a Senior Scientist at Gryphon Schafer where she contributed to development of programs targeting infectious disease threats within BTO. Prior to supporting DARPA, Dr. Jenkins studied the virulence factors of, and antibodies targeting, multi-drug resistant bacterial pathogens at MedImmune.  She also served as a National Research Council Postdoctoral Fellow at the United State Army Medical Research Institute of Infectious Diseases where she studied virulence mechanisms of biodefense pathogens.

She received her Doctor of Philosophy degree in Chemistry and Chemical Biology from Cornell University and her Bachelor of Science in Chemistry and Biomolecular Science from Clarkson University.

Agenda Sessions

  • mRNA Technology for Rapid Response to Pandemic Threats